- Home
- UPB vs STK Comparison
UPB vs STK Comparison
Compare UPB & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- STK
- Stock Information
- Founded
- UPB 2021
- STK 2009
- Country
- UPB United States
- STK United States
- Employees
- UPB N/A
- STK N/A
- Industry
- UPB
- STK Investment Managers
- Sector
- UPB
- STK Finance
- Exchange
- UPB NYSE
- STK Nasdaq
- Market Cap
- UPB 823.6M
- STK 509.5M
- IPO Year
- UPB 2024
- STK N/A
- Fundamental
- Price
- UPB $15.54
- STK $30.59
- Analyst Decision
- UPB Strong Buy
- STK
- Analyst Count
- UPB 4
- STK 0
- Target Price
- UPB $56.50
- STK N/A
- AVG Volume (30 Days)
- UPB 434.2K
- STK 38.2K
- Earning Date
- UPB 08-14-2025
- STK 01-01-0001
- Dividend Yield
- UPB N/A
- STK 6.60%
- EPS Growth
- UPB N/A
- STK N/A
- EPS
- UPB N/A
- STK N/A
- Revenue
- UPB $2,296,000.00
- STK N/A
- Revenue This Year
- UPB N/A
- STK N/A
- Revenue Next Year
- UPB N/A
- STK N/A
- P/E Ratio
- UPB N/A
- STK N/A
- Revenue Growth
- UPB N/A
- STK N/A
- 52 Week Low
- UPB $5.14
- STK $24.95
- 52 Week High
- UPB $29.46
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- STK 50.77
- Support Level
- UPB N/A
- STK $30.98
- Resistance Level
- UPB N/A
- STK $31.44
- Average True Range (ATR)
- UPB 0.00
- STK 0.31
- MACD
- UPB 0.00
- STK -0.06
- Stochastic Oscillator
- UPB 0.00
- STK 27.54
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.